MO‐B‐BRB‐01: Quality Assurance in Stereotactic Radiosurgery and Fractionated Stereotactic Radiotherapy

T. Solberg, D. Shepard

Research output: Contribution to journalArticle

Abstract

Stereotactic radiosurgery involves the high‐dose irradiation of cranial neoplasms delivered in a single fraction. In the 50‐plus years since it was first introduced, stereotactic radiosurgery has become a standard of care in the treatment of brain tumors, vascular malformations, functional disorders, and pain. Modern radiosurgery can be performed non‐invasively and on an outpatient basis while maintaining an extremely high degree of accuracy. Within the past ten years, the field of radiosurgery has seen numerous technological enhancements including: (1) the development of dedicated devices for stereotactic delivery; (2) the use of relocatable frames to facilitate fractionated delivery; (3) the development of “frameless” approaches; and (4) the application to extracranial tumor sites. Each of these developments has been accompanied by its own challenges in assuring targeting and dosimetric accuracy. In this presentation we review the technologies for stereotactic localization and treatment of cranial targets with particular emphasis on the quality assurance aspects associated with establishing and maintaining a clinical radiosurgery program. Specifically, the presentation will: 1. Differentiate the technologies used in the delivery of stereotactic radiosurgery including linac‐based techniques (both conventional and robotic) and the Gamma Knife. 2. Define the treatment planning parameters for linac‐based and Gamma Knife stereotactic radiosurgery. 3. Discuss measures for assuring accuracy in stereotactic localization and dose. 4. delivery for linac‐based and Gamma Knife stereotactic radiosurgery.

Original languageEnglish (US)
Pages (from-to)2513-2514
Number of pages2
JournalMedical Physics
Volume34
Issue number6
DOIs
StatePublished - 2007

Fingerprint

Radiosurgery
Radiotherapy
Central Nervous System Vascular Malformations
Cranial Irradiation
Technology
Somatoform Disorders
Robotics
Standard of Care
Brain Neoplasms
Neoplasms
Outpatients
Therapeutics
Equipment and Supplies

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging

Cite this

MO‐B‐BRB‐01 : Quality Assurance in Stereotactic Radiosurgery and Fractionated Stereotactic Radiotherapy. / Solberg, T.; Shepard, D.

In: Medical Physics, Vol. 34, No. 6, 2007, p. 2513-2514.

Research output: Contribution to journalArticle

@article{5abd961409624b0da1a011b92c8ba0f2,
title = "MO‐B‐BRB‐01: Quality Assurance in Stereotactic Radiosurgery and Fractionated Stereotactic Radiotherapy",
abstract = "Stereotactic radiosurgery involves the high‐dose irradiation of cranial neoplasms delivered in a single fraction. In the 50‐plus years since it was first introduced, stereotactic radiosurgery has become a standard of care in the treatment of brain tumors, vascular malformations, functional disorders, and pain. Modern radiosurgery can be performed non‐invasively and on an outpatient basis while maintaining an extremely high degree of accuracy. Within the past ten years, the field of radiosurgery has seen numerous technological enhancements including: (1) the development of dedicated devices for stereotactic delivery; (2) the use of relocatable frames to facilitate fractionated delivery; (3) the development of “frameless” approaches; and (4) the application to extracranial tumor sites. Each of these developments has been accompanied by its own challenges in assuring targeting and dosimetric accuracy. In this presentation we review the technologies for stereotactic localization and treatment of cranial targets with particular emphasis on the quality assurance aspects associated with establishing and maintaining a clinical radiosurgery program. Specifically, the presentation will: 1. Differentiate the technologies used in the delivery of stereotactic radiosurgery including linac‐based techniques (both conventional and robotic) and the Gamma Knife. 2. Define the treatment planning parameters for linac‐based and Gamma Knife stereotactic radiosurgery. 3. Discuss measures for assuring accuracy in stereotactic localization and dose. 4. delivery for linac‐based and Gamma Knife stereotactic radiosurgery.",
author = "T. Solberg and D. Shepard",
year = "2007",
doi = "10.1118/1.2761203",
language = "English (US)",
volume = "34",
pages = "2513--2514",
journal = "Medical Physics",
issn = "0094-2405",
publisher = "AAPM - American Association of Physicists in Medicine",
number = "6",

}

TY - JOUR

T1 - MO‐B‐BRB‐01

T2 - Quality Assurance in Stereotactic Radiosurgery and Fractionated Stereotactic Radiotherapy

AU - Solberg, T.

AU - Shepard, D.

PY - 2007

Y1 - 2007

N2 - Stereotactic radiosurgery involves the high‐dose irradiation of cranial neoplasms delivered in a single fraction. In the 50‐plus years since it was first introduced, stereotactic radiosurgery has become a standard of care in the treatment of brain tumors, vascular malformations, functional disorders, and pain. Modern radiosurgery can be performed non‐invasively and on an outpatient basis while maintaining an extremely high degree of accuracy. Within the past ten years, the field of radiosurgery has seen numerous technological enhancements including: (1) the development of dedicated devices for stereotactic delivery; (2) the use of relocatable frames to facilitate fractionated delivery; (3) the development of “frameless” approaches; and (4) the application to extracranial tumor sites. Each of these developments has been accompanied by its own challenges in assuring targeting and dosimetric accuracy. In this presentation we review the technologies for stereotactic localization and treatment of cranial targets with particular emphasis on the quality assurance aspects associated with establishing and maintaining a clinical radiosurgery program. Specifically, the presentation will: 1. Differentiate the technologies used in the delivery of stereotactic radiosurgery including linac‐based techniques (both conventional and robotic) and the Gamma Knife. 2. Define the treatment planning parameters for linac‐based and Gamma Knife stereotactic radiosurgery. 3. Discuss measures for assuring accuracy in stereotactic localization and dose. 4. delivery for linac‐based and Gamma Knife stereotactic radiosurgery.

AB - Stereotactic radiosurgery involves the high‐dose irradiation of cranial neoplasms delivered in a single fraction. In the 50‐plus years since it was first introduced, stereotactic radiosurgery has become a standard of care in the treatment of brain tumors, vascular malformations, functional disorders, and pain. Modern radiosurgery can be performed non‐invasively and on an outpatient basis while maintaining an extremely high degree of accuracy. Within the past ten years, the field of radiosurgery has seen numerous technological enhancements including: (1) the development of dedicated devices for stereotactic delivery; (2) the use of relocatable frames to facilitate fractionated delivery; (3) the development of “frameless” approaches; and (4) the application to extracranial tumor sites. Each of these developments has been accompanied by its own challenges in assuring targeting and dosimetric accuracy. In this presentation we review the technologies for stereotactic localization and treatment of cranial targets with particular emphasis on the quality assurance aspects associated with establishing and maintaining a clinical radiosurgery program. Specifically, the presentation will: 1. Differentiate the technologies used in the delivery of stereotactic radiosurgery including linac‐based techniques (both conventional and robotic) and the Gamma Knife. 2. Define the treatment planning parameters for linac‐based and Gamma Knife stereotactic radiosurgery. 3. Discuss measures for assuring accuracy in stereotactic localization and dose. 4. delivery for linac‐based and Gamma Knife stereotactic radiosurgery.

UR - http://www.scopus.com/inward/record.url?scp=85024818373&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024818373&partnerID=8YFLogxK

U2 - 10.1118/1.2761203

DO - 10.1118/1.2761203

M3 - Article

AN - SCOPUS:85024818373

VL - 34

SP - 2513

EP - 2514

JO - Medical Physics

JF - Medical Physics

SN - 0094-2405

IS - 6

ER -